Clinical Trials Logo

Clinical Trial Summary

The C-MIC System is a medical device used to treat heart failure per the intended purpose which is to treat heart failure by applying an electrical micro-current to the heart. Target patients for this study are patients who have received the device in a prior study.


Clinical Trial Description

The C-MIC System is a medical device used to treat heart failure per the intended purpose which is to treat heart failure by applying an electrical micro-current to the heart. The therapy with the C-MIC System is intended to take 6 months. The C-MIC System consists of four parts, of which three are implanted: a transvenous and an epicardial lead and a power source to which the leads are connected. Both leads have the function to transmit micro-current to the heart. A Portable User Terminal (PUT) is needed for programming and readout of the data recorded by the Implantable Microcurrent Device (IMD). Target patients of the C-MIC System at the time of implantation and inclusion in the C-MICII Study were patients with idiopathic dilative cardiomyopathy (NYHA class III - NYHA class who have systolic left ventricular dysfunction despite adequate therapy of heart failure. Target patients for this study are patients who have received the device in a prior study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05189860
Study type Interventional
Source Berlin Heals GmbH
Contact Peter Goettel, MD
Phone +49 30 88913640
Email [email protected]
Status Not yet recruiting
Phase N/A
Start date January 2, 2022
Completion date June 15, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT04662034 - Performance and Safety of the Cardiac Microcurrent Therapy System N/A